Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment
This study investigated how a history of menopausal hormone therapy (MHT) impacts clinical outcomes overall and in different subgroups of breast cancer patients. The study included 814 primary breast cancer patients aged ≥50 years in Sweden (2002–2012) with follow-up until 2016. Associations between...
Main Authors: | Christopher Godina, Erik Ottander, Helga Tryggvadottir, Signe Borgquist, Karolin Isaksson, Helena Jernström |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00080/full |
Similar Items
-
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study
by: Helga Tryggvadottir, et al.
Published: (2021-05-01) -
Modulation of Intracrine Estrogen in Menopausal Women: Implications for Women’s Reproductive Health and Breast Cancer Risk
by: Mousa, Noha
Published: (2010) -
Modulation of Intracrine Estrogen in Menopausal Women: Implications for Women’s Reproductive Health and Breast Cancer Risk
by: Mousa, Noha
Published: (2010) -
Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy
by: Giulia Gava, et al.
Published: (2019-10-01) -
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
by: Linn Nilsson, et al.
Published: (2020-07-01)